Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
Judge Littlefield is deciding whether to permit several child sexual abuse lawsuits against the Roman Catholic Diocese of Albany to go to trial as a method to kick start settlement discussions.
The Supreme Court of the US has rejected a bankruptcy deal that would settle opioid litigation against Purdue Pharma ... pot put on the table to settle claims that Purdue fuelled the opioid ...
A judge in the US has approved the sale of Purdue Pharma’s ... part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billion settlement of claims that it helped to fuel ...
NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy ... to $750 million set aside for personal injury claims in Purdue’s previous bankruptcy plan. Lane said Tuesday that he was ...
Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.
Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.
A decision that would permit a creditor to independently pursue its claim against ... see Purdue Pharma Plan Blocked, Supreme Court Bars Third-Party Releases in Bankruptcy.
Purdue Pharma, 603 U.S. 204 (2024), where a ... third-party nondebtors without the consent of affected claim holders. The bankruptcy bar and courts are now attempting to determine the breadth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results